Terms: = Cervical cancer AND CARS, P49589, 833, ENSG00000110619 AND Staging
5 results:
1. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
2. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of cervical carcinoma at 3.0T: Image quality and FIGO staging.
Chen M; Feng C; Wang Q; Li J; Wu S; Hu D; Deng B; Li Z
Eur J Radiol; 2021 Apr; 137():109557. PubMed ID: 33549900
[TBL] [Abstract] [Full Text] [Related]
3. Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer.
Chen H; Xia B; Zheng T; Lou G
Int J Biol Markers; 2020 Mar; 35(1):65-73. PubMed ID: 31808707
[TBL] [Abstract] [Full Text] [Related]
4. MRI for local staging of endometrial carcinoma: Is endovenous contrast medium administration still needed?
Bonatti M; Stuefer J; Oberhofer N; Negri G; Tagliaferri T; Schifferle G; Messini S; Manfredi R; Bonatti G
Eur J Radiol; 2015 Feb; 84(2):208-14. PubMed ID: 25440994
[TBL] [Abstract] [Full Text] [Related]
5. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
[TBL] [Abstract] [Full Text] [Related]